Table 2.
Patient characteristics at dialysis start according to their care trajectory type
| Type of predialysis care trajectory |
|||||||
|---|---|---|---|---|---|---|---|
| 1 |
2 |
3 |
4 |
5 |
6 |
Total population |
|
| (n = 2299) | (n = 2853) | (n = 1830) | (n = 1121) | (n = 465) | (n = 288) | (N = 8856) | |
| Emergency dialysis start, % | 33.5 | 13.8 | 39.3 | 35.1 | 48.4 | 61.8 | 30.3 |
| eGFR at dialysis start (ml/min per 1.73 m2), median [Q1–Q3] |
9.1 [6.8–12.4] | 8.1 [6.3–10.3] | 8.0 [5.8–10.9] | 7.4 [5.4–9.6] | 6.1 [4.2–8.7] | 6.1 [3.8–8.7] | 8.1 [6.0–10.7] |
| Age, yr | |||||||
| 18–44 | 111 (4.8) | 244 (8.6) | 105 (5.7) | 78 (7.0) | 124 (26.7) | 74 (25.7) | 736 (8.3) |
| 45–59 | 296 (12.9) | 490 (17.2) | 219 (12.0) | 190 (16.9) | 117 (25.2) | 76 (26.4) | 1388 (15.7) |
| 60–74 | 823 (35.8) | 1013 (35.5) | 693 (37.9) | 412 (36.8) | 138 (29.7) | 79 (27.4) | 3158 (35.7) |
| ≥75 | 1069 (46.5) | 1106 (38.8) | 813 (44.4) | 441 (39.3) | 86 (18.5) | 59 (20.5) | 3574 (40.4) |
| Men | 1432 (62.3) | 1816 (63.7) | 1205 (65.8) | 751 (67.0) | 304 (65.4) | 187 (64.9) | 5695 (64.3) |
| Nephropathy type | |||||||
| Slowly progressive nephropathy | 1518 (66.0) | 2113 (74.1) | 1182 (64.6) | 764 (68.2) | 233 (50.1) | 153 (53.1) | 5963 (67.3) |
| Acute nephropathy | 297 (12.9) | 244 (8.6) | 256 (14.0) | 131 (11.7) | 98 (21.1) | 50 (17.4) | 1076 (12.1) |
| Variable/uncertain progression | 484 (21.1) | 496 (17.4) | 392 (21.4) | 226 (20.2) | 134 (28.8) | 85 (29.5) | 1817 (20.5) |
| Number of cardiovascular diseasesa | |||||||
| 0 | 623 (27.1) | 1526 (53.5) | 692 (37.8) | 622 (55.5) | 309 (66.5) | 171 (59.4) | 3943 (44.5) |
| 1 | 585 (25.4) | 674 (23.6) | 491 (26.8) | 258 (23.0) | 85 (18.3) | 65 (22.6) | 2158 (24.4) |
| 2 | 513 (22.3) | 384 (13.5) | 357 (19.5) | 136 (12.1) | 45 (9.7) | 22 (7.6) | 1457 (16.5) |
| ≥3 | 578 (25.1) | 269 (9.4) | 290 (15.8) | 105 (9.4) | 26 (5.6) | 30 (10.4) | 1298 (14.7) |
| Diabetes | 1288 (56.0) | 1207 (42.3) | 868 (47.4) | 429 (38.3) | 103 (22.2) | 91 (31.6) | 3986 (45.0) |
| Missing data | 16 (0.7) | 8 (0.3) | 9 (0.5) | 4 (0.4) | 0 (0) | 3 (1.0) | 40 (0.5) |
| Chronic respiratory disease | 471 (20.5) | 290 (10.2) | 265 (14.5) | 111 (9.9) | 31 (6.7) | 24 (8.3) | 1192 (13.5) |
| Missing data | 68 (3.0) | 81 (2.8) | 56 (3.1) | 32 (2.9) | 10 (2.2) | 13 (4.5) | 260 (2.9) |
| Active malignancy | 356 (15.5) | 191 (6.7) | 216 (11.8) | 119 (10.6) | 41 (8.8) | 19 (6.6) | 942 (10.6) |
| Missing data | 53 (2.3) | 75 (2.6) | 45 (2.5) | 23 (2.1) | 10 (2.2) | 13 (4.5) | 219 (2.5) |
| Mobility | |||||||
| Walk without help | 1575 (68.5) | 2396 (84.0) | 1342 (73.3) | 877 (78.2) | 389 (83.7) | 217 (75.3) | 6796 (76.7) |
| Need assistance | 368 (16.0) | 189 (6.6) | 228 (12.5) | 111 (9.9) | 39 (8.4) | 28 (9.7) | 963 (10.9) |
| Totally dependent | 155 (6.7) | 67 (2.3) | 100 (5.5) | 34 (3.0) | 10 (2.2) | 13 (4.5) | 379 (4.3) |
| Missing | 201 (8.7) | 201 (7.0) | 160 (8.7) | 99 (8.8) | 27 (5.8) | 30 (10.4) | 718 (8.1) |
eGFR, estimated glomerular filtration rate.
Values are n (%) unless otherwise stated.
a
Congestive heart failure, coronary disease, arrhythmia, aortic aneurysm, arteritis of lower limbs, stroke, or transient ischemic attack.